0000950170-24-018033.txt : 20240221
0000950170-24-018033.hdr.sgml : 20240221
20240221165328
ACCESSION NUMBER: 0000950170-24-018033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240216
FILED AS OF DATE: 20240221
DATE AS OF CHANGE: 20240221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Williams Timothy
CENTRAL INDEX KEY: 0001748392
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34186
FILM NUMBER: 24660579
MAIL ADDRESS:
STREET 1: C/O VANDA PHARMACEUTICALS INC.
STREET 2: 2200 PENNSYLVANIA AVENUE NW, SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001347178
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 030491827
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
BUSINESS PHONE: 202-734-3400
MAIL ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
4
1
ownership.xml
4
X0508
4
2024-02-16
0001347178
Vanda Pharmaceuticals Inc.
VNDA
0001748392
Williams Timothy
2200 PENNSYLVANIA AVENUE NW
SUITE 300E
WASHINGTON
DC
20037
false
true
false
false
SVP & General Counsel
false
Common Stock
2024-02-16
4
A
false
125000
0
A
213913
D
Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2025, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
/s/ Timothy Williams
2024-02-21